SANUWAVE HEALTH INC (SNWV) Stock Fundamental Analysis
USA - NASDAQ:SNWV - US80303D3052 - Common Stock
32.97 USD
-0.59 (-1.76%)
Taking everything into account, SNWV scores 2 out of 10 in our fundamental rating. SNWV was compared to 189 industry peers in the Health Care Equipment & Supplies industry. SNWV has a bad profitability rating. Also its financial health evaluation is rather negative. SNWV does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
SNWV had negative earnings in the past year.
In the past year SNWV had a positive cash flow from operations.
In the past 5 years SNWV always reported negative net income.
SNWV had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
SNWV has a worse Return On Assets (-115.07%) than 79.89% of its industry peers.
With an excellent Return On Invested Capital value of 43.52%, SNWV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -115.07% | ||
| ROE | N/A | ||
| ROIC | 43.52% |
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SNWV's Operating Margin of 18.72% is amongst the best of the industry. SNWV outperforms 91.01% of its industry peers.
With an excellent Gross Margin value of 77.69%, SNWV belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
In the last couple of years the Gross Margin of SNWV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.72% | ||
| PM (TTM) | N/A | ||
| GM | 77.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNWV is creating value.
SNWV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SNWV has been increased compared to 5 years ago.
SNWV has a better debt/assets ratio than last year.
2.2 Solvency
SNWV has an Altman-Z score of -6.28. This is a bad value and indicates that SNWV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SNWV (-6.28) is worse than 69.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.28 |
ROIC/WACC4.8
WACC9.07%
2.3 Liquidity
SNWV has a Current Ratio of 0.43. This is a bad value and indicates that SNWV is not financially healthy enough and could expect problems in meeting its short term obligations.
SNWV's Current ratio of 0.43 is on the low side compared to the rest of the industry. SNWV is outperformed by 93.65% of its industry peers.
SNWV has a Quick Ratio of 0.43. This is a bad value and indicates that SNWV is not financially healthy enough and could expect problems in meeting its short term obligations.
SNWV has a Quick ratio of 0.31. This is amonst the worse of the industry: SNWV underperforms 94.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.43 | ||
| Quick Ratio | 0.31 |
3. Growth
3.1 Past
SNWV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.17%, which is quite impressive.
SNWV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.38%.
SNWV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.96% yearly.
EPS 1Y (TTM)34.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-44.38%
Revenue growth 3Y-9.23%
Revenue growth 5Y3.96%
Sales Q2Q%22.34%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year228.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SNWV. In the last year negative earnings were reported.
Also next year SNWV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SNWV is valued a bit cheaper than the industry average as 70.90% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 32.56 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SNWV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SNWV (11/14/2025, 8:27:20 PM)
32.97
-0.59 (-1.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners53.89%
Inst Owner Change2.99%
Ins Owners5.6%
Ins Owner Change0%
Market Cap282.55M
Revenue(TTM)1.03M
Net Income(TTM)-38.03M
Analysts82.5
Price Target55.08 (67.06%)
Short Float %6.15%
Short Ratio6.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.82%
PT rev (3m)10.2%
EPS NQ rev (1m)-12.52%
EPS NQ rev (3m)181.42%
EPS NY rev (1m)-1200%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-7.6%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-6.01%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 7.21 | ||
| P/FCF | N/A | ||
| P/OCF | 188.49 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.56 |
EPS(TTM)-18.75
EYN/A
EPS(NY)-19.12
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.17
OCFY0.53%
SpS4.57
BVpS-1.72
TBVpS-2.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -115.07% | ||
| ROE | N/A | ||
| ROCE | -54.54% | ||
| ROIC | 43.52% | ||
| ROICexc | 120.2% | ||
| ROICexgc | N/A | ||
| OM | 18.72% | ||
| PM (TTM) | N/A | ||
| GM | 77.69% | ||
| FCFM | N/A |
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
F-Score5
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 129.65% | ||
| Cap/Sales | 4.1% | ||
| Interest Coverage | 1.63 | ||
| Cash Conversion | 17.48% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.43 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z | -6.28 |
F-Score5
WACC9.07%
ROIC/WACC4.8
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.38%
Revenue growth 3Y-9.23%
Revenue growth 5Y3.96%
Sales Q2Q%22.34%
Revenue Next Year228.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y406.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.56%
EBIT Next 3Y60.99%
EBIT Next 5YN/A
FCF growth 1Y99.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111.37%
OCF growth 3YN/A
OCF growth 5YN/A
SANUWAVE HEALTH INC / SNWV FAQ
Can you provide the ChartMill fundamental rating for SANUWAVE HEALTH INC?
ChartMill assigns a fundamental rating of 2 / 10 to SNWV.
What is the valuation status for SNWV stock?
ChartMill assigns a valuation rating of 1 / 10 to SANUWAVE HEALTH INC (SNWV). This can be considered as Overvalued.
What is the profitability of SNWV stock?
SANUWAVE HEALTH INC (SNWV) has a profitability rating of 3 / 10.
What is the earnings growth outlook for SANUWAVE HEALTH INC?
The Earnings per Share (EPS) of SANUWAVE HEALTH INC (SNWV) is expected to decline by -2% in the next year.